Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NIH Funds Influenza Research and Surveillance Network

Published: Friday, April 11, 2014
Last Updated: Friday, April 11, 2014
Bookmark and Share
NIAID-supported centers integrate research to improve pandemic preparedness.

Influenza scientists at five sites in the United States are to receive funding from the National Institute of Allergy and Infectious Diseases (NIAID) to collaborate with investigators around the globe in a network designed to advance understanding of influenza viruses and how they cause disease.

In addition to basic research, investigators in the Centers of Excellence for Influenza Research and Surveillance (CEIRS) network also conduct domestic and international influenza surveillance studies with an emphasis on rapid characterization of viruses that have the potential to cause pandemics.

The first CEIRS network was launched in 2007 by NIAID, part of the National Institutes of Health. NIAID has announced awards of the new contracts to continue the program for seven years.

“The CEIRS network exemplifies NIAID’s dual mission of conducting basic and applied influenza research, while maintaining the ability to respond rapidly in the event of an emerging public health threat,” said NIAID Director Anthony S. Fauci, M.D. “CEIRS investigators have contributed greatly to our understanding of how influenza viruses emerge from wild and domestic animals, their adaptation to and global circulation throughout the human population and the interplay between the viruses and human immune responses.” Dr. Fauci added that the CEIRS network also played a critical role in the nation’s response to the 2009 H1N1 influenza pandemic by, for example, quickly characterizing the virus and performing pre-clinical testing of candidate vaccines.

The geographic range of sample collection sites will be more tightly focused than previously on those regions where new influenza viruses are likely to emerge and the network will further integrate basic research with surveillance data gathering, said CEIRS project officer Diane Post, Ph.D., of NIAID’s Division of Microbiology and Infectious Diseases.

“A key mission of the CEIRS network is to foster innovative and collaborative basic research on influenza viruses, including how they evolve and adapt to animal and human hosts. The information we gain could help us understand why influenza pandemics occur and could assist health officials in taking steps to mitigate outbreaks,” Dr. Post said.

Four of the new CEIRS contracts are to institutions that had received a 2007 award. One institution, Johns Hopkins University, will establish a new center. All will conduct surveillance and basic research projects. The network has a global reach, with collaborations established or planned at more than two dozen sites in Asia, Southeast Asia, the Middle East, South America, Europe and Australia. Funding for the first year of the contracts will total approximately $23 million.

“Proposed work from all five centers involves new and exciting research programs that hold the promise to answer fundamental questions pertaining to influenza in animals and people,” said Dr. Post.

The centers are based at

Emory University, Atlanta

Emory-UGA Center of Excellence for Influenza Research and Surveillance (CEIRS) External Web Site Policy
Walter Orenstein, M.D., principal investigator
Richard Compans, M.D., co-principal investigator

In partnership with the University of Georgia (UGA), Emory University studies will focus on surveillance of swine influenza viruses and investigations of swine immune responses to virus infection. With collaborators in China, animal surveillance efforts will include swine and poultry. Basic research projects at Emory-UGA CEIRS will include efforts to better understand the human immune response to influenza vaccination, including responses of pregnant women. Planned studies of long-lasting flu antibodies could aid in the development of influenza vaccines that would provide years-long immunity to multiple strains of flu.

Icahn School of Medicine at Mount Sinai, New York City

Center for Research on Influenza Pathogenesis (CRIP) External Web Site Policy
Adolfo Garcia-Sastre, Ph.D., principal investigator

CRIP will provide an active and comprehensive animal influenza surveillance structure and will contribute to better understanding of the range of animals that can be infected by various influenza viruses and virus ecology, and the factors leading to the generation of pandemics. Planned animal surveillance studies include surveys of marine mammals and wild birds in the Atlantic region; information from these surveys could shed light on virus evolution in animal reservoirs. Basic research will include continued investigations of virus-host interactions aimed at revealing why some influenza virus types cause more serious disease than others.

Johns Hopkins University, Baltimore

Richard Rothman, M.D., Ph.D., principal investigator
Andrew Pekosz, Ph.D., co-principal investigator

Investigators plan active and passive surveillance studies of human flu strains in the United States and Taiwan with the goal of rapidly identifying exactly which strains are circulating over the course of each flu season. This would allow annual influenza vaccines to better match the circulating strains. Among the basic research projects planned is one that will probe the impact of influenza virus infection on human respiratory epithelial cells.

St. Jude Children’s Research Hospital, Memphis, Tenn.

St. Jude Center of Excellence for Influenza Research and Surveillance
Richard Webby, Ph.D., principal investigator
Stacey Schultz-Cherry, Ph.D., co-principal investigator

Scientists will further their investigations into how certain avian influenza viruses, for example, H7N9 avian influenza, jump the species barrier and become capable of infecting people and other mammals, while others never make this leap. In addition to studying wild bird populations in Canada and the United States, scientists associated with the St. Jude CEIRS will conduct animal surveillance studies at sites in Bangladesh, China, Colombia and Egypt. Basic research on transmission of flu virus in swine will include studies of the aerodynamics of virus-containing particles.

University of Rochester Medical Center, Rochester, N.Y.

New York Influenza Center of Excellence (NYICE) External Web Site Policy
John Treanor, M.D., principal investigator
David Topham, Ph.D., co-principal investigator

Basic research projects include efforts to understand the full scope of human immune system reactions to infection and vaccination. A strong emphasis is on comprehensive analysis of the cells in the immune system that determine susceptibility to infection. A long-term goal is to improve the design of flu vaccines so that they provide better protection against illness. Other projects include collection of blood samples from adults and children with acute influenza and from household members without symptoms to better understand immune system responses over the course of illness or following exposure not resulting in illness. Investigators also plan to study how social media platforms might be used to collect real-time data on flu outbreaks.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NIH Funds Biobank To Support Precision Medicine Initiative Cohort Program
$142 million over five years will be awarded to the Mayo Clinic to establish the world’s largest research-cohort biobank for the PMI Cohort Program
Friday, May 27, 2016
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Friday, May 27, 2016
New NIH-EPA Research Centers to Study Environmental Health Disparities
Scientists will partner with community organizations to study these concerns and develop culturally appropriate ways to reduce exposure to harmful environmental conditions.
Thursday, May 26, 2016
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
Wednesday, May 25, 2016
Visual Impairment, Blindness Cases in U.S. Expected to Double by 2050
Researchers at NIH have suggested that there is a need for increased screening and interventions to identify and address treatable causes of vision loss.
Friday, May 20, 2016
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Wednesday, May 18, 2016
NIH Funds New Studies on Ethical, Legal and Social Impact of Genomic Information
Four new grants from the National Institutes of Health will support research on the ethical, legal and social questions raised by advances in genomics research and the increasing availability of genomic information.
Wednesday, May 18, 2016
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
Wednesday, May 18, 2016
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Tuesday, May 17, 2016
Researchers Identify Genetic Links to Educational Attainment
Researchers at NIH have suggested that the large genetics analyses may be able to help discover biological pathways as well.
Thursday, May 12, 2016
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
Tuesday, May 10, 2016
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Thursday, May 05, 2016
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
Wednesday, April 27, 2016
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Thursday, April 21, 2016
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
Wednesday, April 20, 2016
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Study Identifies How Brain Connects Memories Across Time
UCLA Neuroscientists have boost ability of aging brain to recapture links between related memories.
3-D Atomic Structure of Cholesterol Transporter
Researchers at UTSW have determined the 3-D atomic structure of a human sterol transporter that helps maintain cholesterol balance.
First Large-Scale Proteogenomic Study of Breast Cancer
The study offers understanding of potential therapeutic targets.
Can We Break the Link Between Obesity and Diabetes?
Columbia University researchers identify a key molecule involved in the development of type 2 diabetes.
Fungi – A Promising Source Of Chemical Diversity
Moulds and plants share similar ways in alkaloid biosynthesis .
How Prions Kill Neurons: New Culture System Shows Early Toxicity to Dendritic Spines
Boston University researchers have developed a cell culture system to study prions.
Great Migration and African-American Genomic Diversity
Study examines genetic data to analyze regional differences in ancestry.
Faster, More Efficient CRISPR Editing
UC Berkeley scientists have developed a quicker and more efficient method to alter the genes of mice with CRISPR-Cas9, simplifying a procedure growing in popularity because of the ease of using the new gene-editing tool.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!